References
- Grau A, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S, et al. Risk factors, outcome and treatment in subtypes of ischaemic stroke: the German stroke data bank. Stroke. 2001;32:2559-66.
- Ammirati E, Moroni F, Norata G, Magnoni M, Camici P. Markers of inflammation associated with plaque progression and instability in patients with carotid atherosclerosis. Mediators Inflamm. 2015;2015:718329.
- Stary H, Chandler A, Dinsmore R, Fuster V, Glagov S, Insull W, et al. A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis. A Report From the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1995; 92:1355-74.
- Osborn E, Jaffer F. Imaging atherosclerosis and risk of plaque rupture.Curr Atheroscler Rep. 2013; 15(10):359.
- Gray-Weale A, Graham J, Burnett J, Byrne K, Lusby R. Carotid artery atheroma: comparison of preoperative Bmode ultrasound appearance with carotid endarterectomy specimen pathology. J Cardiovasc Surg. 1988;29:676-81.
- Cai J, Hatsukami T, Ferguson M, Small R, Polissar N, Yuan C. Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation. 2002;106:1368-73.
- van Oostrom O, Velema E, Schoneveld A, de Vries J, de Bruin P, Seldenrijk C, et al. Age-related changes in plaque composition: a study in patients suffering from carotid artery stenosis. Cardiovasc Pathol. 2005;14(3):126-34.
- Pelisek J, Wendorff H, Wendorff C, Kuehnl A, Eckstein H. Age-associated changes in human carotid atherosclerotic plaques. Ann Med. 2016;48(7):541-51.
- Pasceri V, Willerson J, Yeh E. Direct proinflammatory effect of C-reactive protein on human endothelial cells.Circulation. 2000;102:2165-8.
- Levenson J, Giral P, Razavian M, Gariepy J, Simon A. Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors. Arterioscler Thromb Vasc Biol. 1995;15:1263-8.
- Chia M. The role of adhesion molecules in atherosclerosis. Crit Rev Clin Lab Sci. 1998;35(6):573-602.
- Debing E, Peeters E, Demanet C, De Waele M, Van den Brande P. Markers of inflammation in patients with symptomatic and asymptomatic carotid artery stenosis: a case-control study. Vasc Endovascular Surg. 2008;42(2):122-27.
- Hashimoto H, Kitagawa K, Hougaku H, Shimizu Y, Sakaguchi M, Nagai Y, et al. C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation. 2001;104(1):63-7.
- Puz P, Lasek-Bal A, Ziaja D, Kazibutowska Z, Ziaja K. Inflammatory markers in patients with internal carotid artery stenosis. Arch Med Sci. 2013;9(2):254-60.
- Rost N, Wolf P, Kase C, Kelly-Hayes M, Silbershatz H, Massaro J, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke. 2001;32(11):2575-9.
- Di Napoli M, Elkind M, Godoy D, Singh P, Papa F, Popa-Wagner A. Role of C-reactive protein in cerebrovascular disease: a critical review. Expert Rev Cardiovasc Ther. 2011;9(12):1565-84.
- Peycheva M, Deneva T, Zahariev Z.High-sensitive CRP in ischemic stroke patients-from risk factors to evolution. Cesk Slov Neurol N. 2019;82(5): 549-55.
- Surma S, Banach M. Fibrinogen and Atherosclerotic Cardiovascular Diseases-Review of the Literature and Clinical Studies. Int J Mol Sci. 2021;23(1):193.
- Papagianni A, Kalovoulos M, Kirmizis D, Vainas A, Belechri A, Alexopoulos E, et al. Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients. Nephrol Dial Transplant. 2003;18(1):113-9.
- Hulthe J, Wikstrand J, Mattsson-Hultén L, Fagerberg B. Circulating ICAM-1 (intercellular cell-adhesion molecule 1) is associated with early stages of atherosclerosis development and with inflammatory cytokines in healthy 58-year-old men: the Atherosclerosis and Insulin Resistance (AIR) study. Clin Sci (Lond). 2002;103(2):123-9.
- Best P, Gersh B. Cell adhesion molecules and inflammation in acute coronary syndromes: markers and emerging risk factors. Eur Heart J. 2001;22(14):1155-9.
- Benbir G, Bozluolcay M, Ince B. Is the level of C-reactive protein correlated with the extent of carotid atherosclerosis? Acta Neurol Belg. 2005;105(2):73-80.
- Musialek P, Tracz W, Tekieli L, Pieniazek P, Kablak-Ziembicka A, Przewlocki T, et al. Multimarker approach in discriminating patients with symptomatic and asymptomatic atherosclerotic carotid artery stenosis. J Clin Neurol. 2013;9(3):165-75.
- Sabeti S, Exner M, Mlekusch W, Amighi J, Quehenberger P, Rumpold H, et al. Prognostic impact of fibrinogen in carotid atherosclerosis: nonspecific indicator of inflammation or independent predictor of disease progression? Stroke. 2005;36(7):1400-4.
- Brinjikji W, Rabinstein A, Lanzino G, Murad M, Williamson E, DeMarco J, et al. Ultrasound Characteristics of Symptomatic Carotid Plaques: A Systematic Review and Meta-Analysis. Cerebrovasc Dis. 2015;40(3-4):165-74.
- Moreno P. Vulnerable plaque: definition, diagnosis, and treatment. Cardiol Clin. 2010;28(1):1-30.
- den Hartog A, Bovens S, Koning W, Hendrikse J, Luijten P, Moll F, et al. Current status of clinical magnetic resonance imaging for plaque characterisation in patients with carotid artery stenosis. Eur J Vasc Endovasc Surg. 2013;45(1):7-21.
- Weiss C, Arai A, Bui M, Agyeman K, Waclawiw M, Balaban R, at al. Arterial wall MRI characteristics are associated with elevated serum markers of inflammation in humans. J Magn Reson Imaging. 2001;14(6):698-704.
- van Dijk A, Donkel SJ, Zadi T, Sonneveld M, Schreuder F, Chohan M, et al. Association between fibrinogen and fibrinogen γ’ and atherosclerotic plaque morphology and composition in symptomatic carotid artery stenosis: Plaque-At-RISK study. Thromb Res. 2019;177:130-5.
- Lombardo A, Biasucci L, Lanza G, Coli S, Silvestri P, Cianflone D, et al. Inflammation as a possible link between coronary and carotid plaque instability. Circulation. 2004;109(25):3158-63.
- Rohde L, Lee R, Rivero J, Jamacochian M, Arroyo L, Briggs W, et al. Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 1998;18(11):1765-70.
- Shindo A, Tanemura H, Yata K, Hamada K, Shibata M, Umeda Y, et al. Inflammatory biomarkers in atherosclerosis: pentraxin 3 can become a novel marker of plaque vulnerability. PLoS One. 2014;9(6):e100045.